ABVX
Abivax SA American Depositary Shares
Mentions (24Hr)
0.00% Today
Reddit Posts
A proper oldschool DD that's probably a 2-3 bagger by end of year. $ABVX
03 JUNE 2026 , WHAT ARE THE BIGGEST LOSERS ?
I’m still not healthy for retirement. ABVX helped a little with the jump.
I doubled in 1 year. ABVX was the big jump.
BIOA is about to reprice much higher but you need to be awake and have faith
Getting obliterated on one account, but crushing the other account... normal?
$CGTX, Upcoming Plans - Comprehensive Discussion with the IR Representative
$EQ is complicated, but here is the lowdown (hint: it is a massive long)
Help figuring things out and avoiding temptations, long term, first time investor
" We highlight the company is funded through a key event for 2025, the P3 top line data for Gps which is expected mid-year "
Learning my lessons from stocks like $ABVX for betting on clinical stage biotech.DO they
[DD] The ABIVAX (ABVX) “Oral Colitis Cure” play
ABIVAX – Scénario de valorisation long terme (analyse claire et chiffrée)
Abivax (ABVX SA): A High-Potential Biotech with Momentum in Ulcerative Colitis
Mentions
Market has been a chop fest. You won’t make good money quickly unless you can actually locate an asymmetrical opportunity and size it large. That’s the opposite of splitting 1k three ways. And in reality, you split it hundreds to thousands of ways. I know the dividend etf. Are the others ETFs too? Put the 1k on one growth company or beaten down blue chip that you have confidence in. Know WHY you have conviction in the name. This requires RESEARCH. If you’re not willing to research just put it all in SCHB and know that you may make $100 in a year. For starters: GRAB, OUST, UBER, NBIS, IDN, ABVX, UUUU, NFLX, NKE. There’s a good mix. Use Claude for learning.
ABVX has the laziest webmaster, or is getting bought out after hours.../s
It's a phase 3 study about to end. Go look up what happened with RVMD, ABVX, hell even MRNA recently when their phase 3 results ended.
Bio is definitely moving. Look at year to date charts for RVMD, DRTS and SLS. Flat all year then jump mid April/ mid May a new plateau. Then June 15th all of them climbed fast to where they are now. ABVX chart would have looked the same but for a trial death that was found to be unrelated (see huge, obvious dip I missed :( I'm continuing to buy. DRTSW and RVMDW warrants move with more torque. They're up like 1000% this year. Can't believe no one talks about warrants.
Offering increased from **$600M to $800M!! Insane demand**. $ABVX🚀🚀
$ABVX just released the best results for their UC drug and the price is still under where it was prior to P3 readout. If you want to scalp something for a quick profit over the next couple weeks
Didn’t get bagged by ABVX after all. Buyout at $160+ incoming
Probably getting bagged by ABVX after hours
Can I recommend ABVX instead?
Take a some of it and buy ABVX under a hundred. Wait until the company gets bought out in a year or flip it when the data comes out refuting the idea that their drug created cancer inside the patients. Look into it, this isn't some sort of pump It's a 7 billion dollar company minimum.
Of all the stocks to buy calls on I chose ABVX
ABVX - that drop was an overreaction on positive news.
ABVX is such a rollercoaster. They release positive phase 3 trial data, the stock rallies from 130 to 170, then dumps to 65 and is about 95 now. Crazy ride
ABVX best data I’ve ever seen, wow. *stock down 50%*
I bought ABVX on this dip that I think makes no sense. They had great trial results but someone got nervous over 1 outlier result that seems like a nothing burger.
The thing is even if it isn’t bought out it still has the chance of running up to $100+. ABVX or whatever the stock was that ran up last year went from like $5-6, jumped to I think $50-60 after they dropped their data, then kept going up to the $140 range and it’s $126 as I’m typing. I think whether or not we get bought out we will ball out but the buyout is the icing on the cake. Imagine if it takes a little while for the BO and we do get up to $100+, we could see close to $200 or more for the SP if that shit happens. I’m not saying a BO will be delayed but depending on what’s going on behind closed doors we have a multitude of outcomes that in my mind are all positive.
Thank you, I'm glad the due diligence is helpful and insightful. And I've been a deep value investor for several years and am semi-retired, but I really enjoy working and continue with deep value investing. Have a lot of years of experience in business, software engineering, machine learning/statistics, and a strong understanding of healthcare and pharma gained over time. And it really is 99.99% chances statistically, I know I sound crazy when I say that, but it's the truth. The 8 ML models ensemble I built predict the 80th event will occur in the range of Sept/Oct 2026 to April/May 2027. As for your question on the impact the REGAL final analysis readout will have on shares, I believe the move will be a lot like ABVX. ABVX's drug (Obefazimod) is for Ulcerative Colitis (UC), a crowded market dominated by AbbVie (Humira) and Pfizer (Xeljanz). Their Phase 3 Data: They crushed the placebo. 50mg Dose: 19.3% remission rate vs. 2.5% for placebo (Study 1). A 17% improvement in a disease where 10% is considered good. Wall Street realized instantly that this would become a standard of care. The buyout probability went to 100%, hence the 10X surge to $60 a share, which was like 1B in market cap gain in one day, dilution came afterwards. GPS 3-4X's survival (saves lives) in AML CR2 (not eligible for transplant), and there is a cure fraction with 62% to 68% predicted by the unconstrained grid search (which happens to align with the GPS immune response rate numbers), it will dominate CR1 given the results in CR2 (not eligible for transplant) and the cure fraction (it already beat Onureg in CR1 without unlimited dosing achieving 67 mOS in Phase 2 within CR1), and enters a market (CR2 Maintenance) with ZERO competitors. It is a monopoly from Day 1 for at least 5 to 8 years. ABBV and BMS will need to acquire SLS, the one that does will lose a ton of revenue, AbbVie will lose billions in revenue. The surge and buyout following will be astronomical within the range (10B-40B). https://preview.redd.it/s4wtj59qbqpg1.png?width=1911&format=png&auto=webp&s=b7e30ff41ac129b8c989a9eb70e8a364834f702f
Not only will this company help so many people in need a g better life, but what a great investment opportunity! I am no worried about the shorts or the daily. I fully expect to wake up one day and it be the same as ABVX last July. It flatlined forever, then wake up one day and it went from like $7 to $70. No need to worry about the shorts in that situation! I certainly have enough of this company, but I will continue to purchase till that day. Truly a hidden Gem. Easy buy and hold, even in this market.
LQDA - went from 12$ to 45$ in a span of a year. Shkreli had a post about the company on WSB 2 year ago RVMD - oncology drug maker. WSJ was reporting multiple companies including Merck are interested in a buyout. 3x in year. ABVX another biotech buyout target
I'm all ears! I haven't looked into ABVX at all. Why do you like it?
Remove VEEV and HIMS, add ABVX
LLY jet is in Paris possibly making a deal to buy ABVX at 100% premium but here you are in the big 26 trading amazon and microsoft
The recent Market Action is telling all who don't know or who aren't sure, - Gps is 100% for Sure Getting FDA Approval and that SLS is worth F Ton More than what shorts sold it Down for - What is GPS TRULY WORTH? Incoming Phase 3 Results for GPS Immunotherapy are offering a true Once in a Lifetime Investment Opportunity. $.64b Manipulated Market Cap worth $40B to Big Pharma the Instant the Phase 3 Results are Announced. **- The Value of a Positive Phase 3 Result exceeds $40B, more than 77x the current manipulated $.6b mcap. SLS Share Price will continue climbing until the P3 Results are released, and then it Launches.** \- Big Pharma's Pay 4X Revenue Multiples in buyouts. \- 12,500 AML CR2/CR3 Patients Each Year\* - current P3 Setting. SLS published est\* rev per patient of $280K /year. \*\*- $3.5B Year 1 TAM\*\* Currently 5-7,000 AML CR2 Patients Who Also Will Be Immediately Eligible for Gps Immunotherapy right out of the Gate upon approval: 5,000 \* $280k = $1.4B **Year 1 Total Addressable Market $4.9B** for Just for AML CR2/3 - the Setting for the Phase 3 Trial. AND THEN COMPOUND IT - Infinite Dosing to Until Relapse \- Year 1 Rev $280K Per Patient / 15 Doses - Year 2 Rev $112K Per Patient / 6 Doses \- Year 3+ Rev $70K Per Patient / 4 Doses the Ad Infinitum Dosing Regime Doubles the Total Addressable Market for AML CR2 CR3 Then Add AML CR1/ Post ASCT - 5X the SIZE of CR2/3 Esp w VIALE-M CR1 Trial Failing and VIALE-T P/Asct Failing. **You absolutely Know Big Pharma Will be Adding AML CR1 Patient and AML Post Asct Patient Populations to the Potential Revenue Calculations.**Gps will be Effective in over 20 different cancer settings that harbour WT1 +. GPs has already proven effective in Mesothelioma and Platinum Resistant Ovarian Cancer settings, achieving better Phase 2 Combination trial Results with Keytruda $MRK - MOS of 18.4 months - than, Elahere $IMGN 16.4 Months, which earned FDA Approval and was bought by $abbv for $10.1B - this is just 1 comp worth $10B. \* Sources available upon request \-- ABVX was a $5 and change Equity prior to releasing its Phase 3 Trial Results - it launched on the P3 announcement - T1 Trading Halt and a Gap UP opening at $60 and it Kept on Climbing to a high of $145. \- buyout expected/
I'd ask for an invite but I don't think I fit in this crowd anymore. Blew up my account and swore off options two years ago. Stuck with boring monthly ETF purchases since for the most part. Can't seem to stop playing pharma stocks once in a while (most recent was ABVX - bought at $120, sold at $132) and I'll never stop loading into ZIM (still waiting for the buyout).
Hell yeah. Don’t get back in- idk anything about pharma but my MIT startup friend says buy and hold ABVX so that’s where I’m at Aside from daily otm credit bear spreads on SPX the past few days
SNOW IGV positions being built. Also think ABVX gets a buyout offer by EOM.
NVO needs to make a partnership with $HIMS along with buying out ABVX. Use the hims partnership to sink LLY on pricing.
ABVX in buy and chill territory with huge BO rumors from NOVO and AZ, 100% premium potential and trading at the bottom of its holding pattern rn
Right now I have 1/3rd of my portfolio in ABVX waiting for a rumored buyout. Fingers crosses.
Now we know why there was a big ABVX call buy last week 🙄 https://preview.redd.it/i5qvmqng6xcg1.jpeg?width=1206&format=pjpg&auto=webp&s=a647e6c7da84c0b9b80a6b08c4339b2c8b077562
If you like ABVX, SLS might be worth a DD.
ABVX waiting for result announcement on Feb
Abivax (ABVX) baggies praying for a buyout today or it's doomed!!
The response is applicable to both. ABVX had the big jump after results, typical, and now the price is being steadily walked up for a $200 buyout.
Thanks, my question was about ABVX. I’m more versed in SLS.
Anyone who doesn't believe, go look at the ABVX chart
$SLS is going to rip faces off just like $ABVX
I’m just a retail investor, I wouldn’t trust me. But if the thesis plays out and the REGAL trial is proved to be a success (the CEO saying we’re at 72 events is as close to confirming that it works, without launching a full blown PR, in my eyes), it wouldn’t surprise me if it went from $4 to at least $65 overnight similar to ABVX. If you peruse the SLS forums, there’s enough posts talking about the TAM of both GPS and SLS009 for AML and what that would do for the share price, so with that in mind, I still think we’re early. I told myself if SLS is still sub 5 in the new year, I’ll put another 25k into it. But do your own research and risk what you can afford to lose. Biotech is brutal.
Stock Price shouldn't be compared, market cap should be. ABVX crawled from 5 to 10 over a couple months. Then positive results and a near 7x. Then a bit more of a double from there over the following 6 months.
Spacs in 2020. Then held rklb for 4 years. Sold at 40. Since then I traded various stocks. Companies I was familiar with, or catches a knife, like unh. Currently holding long term GLSI and CDR. Just added some ABVX and IMSR for quick profit. I also hold ton of long term puts on PLTR, GOOG. Coz I think the bubble pops this year. Look at 2011 silver/gold. Once that pops market goes shortly after
I’m still holding a few thousand shares, but biotech is always risky. A lot of good science has gotten burned by unexpected results. I don't disagree with the science and I’m bullish on peptides over chemo, but this is still a pennystock community and while I would love to see a 10-20x I'm not as confident that we will see a huge jump like ABVX due to the smaller TAM. Wishing everyone who's holding huge positions nothing but the best. I just don't have that risk tolerance for something like this.
There's more to it than it being a better treatment. I believe in peptide treatment over chemo yes. What I'm concerned more about is that this is a smaller market than something like ABVX which people have been comparing it to. So that's the biggest risk here is if it is ready for mass commercialization, what that looks like and what is the upside. For it to take market share it has to be able to outperform the incumbent by a sizeable margin. That's what we're all waiting to see with the OS data and how patient care looks.
The timeframe is hard to predict of course especially in the face of increased survival. Short term the stock will likely climb higher into january option expiry and then a violent short/gamma squeeze could send it vertical into double digits ahead of data. Clinical data then will again be a multi X and from there we are close to a BO multiple with maybe 100% premium. Check ABVX chart for reference how these things play out. Do your own research don't trust strangers on the internet.
Buyout targets 2026 Q1: ABVX, AIG, TERN
There is reason to believe LLY will buy out ABVX this week or next. They have what appears to be the next blockbuster Crons disease oral drug (currently only injections exist).
My 2026 predictions (please take my post seriously): ABVX getting bought out Q1 (cannot buy on Robinhood). Silver $100 Q1. AIG bought out Q1. TGT will hit $120 in Q1. TERN will get bought out above $50 in Q1.
I’m up about 30% on my ABVX which is ironically about how much I was up on my QURE before I got rugpulled by the FDA lol. I don’t learn anything because I’ve put a lot more into ABVX, hopefully it pays off
I see you’re a fan of getting bent by bio. Have a try at ABVX friend
ABVX. They are in takeover talks with Eli Lilly. Very promising drug.
I thought ABVX meets the requirements. My bad. Thanks for tip on r/investing
How did you make out with ABVX? I was in pre $10 and sold 90% of my holdings in July at $63. Wish I held longer. I still have a nice amount while waiting for the M&A. But damn, I wish I didn’t get spooked in July and I just held everything. I could retire now if I did. Oh well. Can’t get greedy. It will take you down.
Yes. And my dad is ABVX. He was very good to me.
Claims he’s 'not doing well' with a 1.3M portfolio and a 1-year double. Classic. If that’s performing poorly, I should probably just delete my app. I'm over here sweating over my 10% speculative cap in RKLB and ASTS while you’re speed-running retirement on ABVX. Congrats and f\* you
Yall should’ve been buying ABVX like me since the 90s 🤴
$SLS. The next ABVX, on its way to buy out and $50/share.
The next ABVX, on its way to buy out and $50/share.
The next ABVX, on its way to buy out and $50/share.
The next ABVX, on its way to buy out and $50/share.
ABVX buyout seems to be around the corner
Buy ABVX for the Monday buyout
is that not ABVX and not ABVE? lmao
Selling $ABVX covered puts for December
Crazy that nobody paid attention to ABVX
check out $QURE and $ABVX, big binaries coming with voucher for approval on QURE (regardless of if it works or not, long story lmao look into FDA dealing with DMD and serepta..) and ABVX will likely get FDA approval and/or acquired this year or next year. I'm in shares and have been for a bit but considering calls.
OP please sell. Go put your money into any these. STEX ABVE CRML SPRB ABVX DVLT NUAI AGH VOR ONDS SNLH TRON
I have a scanner there’s ways to find them. Basically high ADR like > 3.5 , high beta, high 1M, 3m, 6month cumulative returns, high dollar volume (volume * price). Rank the top decile. search “qualmaggie setup” it’s basically a momentum breakout. Crazy high returns. Today I made 30% on NEGG, DVLT and NUAI and a a bunch on ABVE yesterday. There is an eb and flow to crazy high beta stocks. Look at some of these companies. Bet you have never heard of them. STEX ABVE CRML SPRB ABVX DVLT NUAI AGH VOR ONDS SNLH TRON
I have a scanner there’s ways to find them. Basically high ADR like > 3.5 , high beta, high 1M, 3m, 6month cumulative returns, high dollar volume (volume * price). Rank the top decile. search “qualmaggie setup” it’s basically a momentum breakout. Crazy high returns. Today I made 30% on NEGG, DVLT and NUAI and a a bunch on ABVE yesterday. There is an eb and flow to crazy high beta stocks. Look at some of these companies. Bet you have never heard of them. STEX ABVE CRML SPRB ABVX DVLT NUAI AGH VOR ONDS SNLH TRON
same! ABVX is for Ulcerative Colitis but because it's an inflammatory drug it may be used for Crohn's and if truly inflammatory a whole slew of diseases that are created by inflammation! my ears def perked up when hearing that!
yeah i was watching an interview today about IMRX, QURE, and ABVX. All close to basically curing or changing the face of an illness or issue. QURE is for Huntington's Disease and ABVX is inflammatory disease.
ABVX Good thing i bought shares last week. Money printer fr
I bought options last Friday and also shares. Update - ABVX presented and met both primary endpoints for their pivotal trials. Stock gonna move at least 30% up premarket tomorrow
Yeah options on ABVX probably isn't worth it. Shares for now. If they keep pushing out good data on their ulcerative collitis drugs they will be a $20Bn company very quickly.
The spread on ABVX is insane..good luck tho
Thank you for the kind words but don't be sorry for a colossal idiot such as myself. I foolishly invested a substantial portion of my portfolio and even though I was in excess of %100 up back in July, I ignored all the advice in the world to trim back at least half.The ABVX price spikes didn't help because it really boosted my false optimism and warped my perception of what a binary event really is. It's easy to blame greed but I know deep down it wasn't that, I have minimal interest in material possessions, I just wanted a specific outcome at the end of this year for my family. Reminder to all, the stock market is not anyone's friend and has a merciless disregard for hopes and dreams! At least some tech plays have made up half the losses, but in a bull market everyone seems to be a genius...
AVO calls ABVX puts CASY puts
I dont think there’s an options chain for ABVX
Anyone able to find ABVX on robinhood? Pops up elsewhere
I put my money in ABVX, SOFI, and HOOD. Pretty sure every one of those have outperformed reddit. Still a hard no
Research List KLAC FCX ON MU TER SYM SMR TEM ABVX I saved all these tickers and can't remember why... Are any winners in there or was I going down regarded rabbit holes because I was up passed my bedtime?